Kimberly Scearce‐Levie

10.5k citations

55 papers · 5.8k indexed · 1 hit paper · h-index 35

Physiology top 0.5%
Molecular Biology top 5%
Cellular and Molecular Neuroscience top 0.5%
Pharmacology top 0.5%
Neurology top 0.5%

Co-authors: Lennart Mucke Jorge J. Palop Hertzel C. Gerstein Irene H. Cheng Tiffany Wu Gui-Qiu Yu Fengrong Yan Erik D. Roberson
Topics: Alzheimer's disease research and treatments (20 papers)Neuroscience and Neuropharmacology Research (17 papers)Neurotransmitter Receptor Influence on Behavior (10 papers)
Cited by: Cellular and Molecular Neuroscience Physiology Neurology
Journals: Nature Science Proceedings of the National Academy of Sciences
Partner nations: United States France Singapore

In The Last Decade

Kimberly Scearce‐Levie

55 papers receiving 5.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Reducing Endogenous Tau Ameliorates Amyloid ß-Induced Deficits in an Alzheimer's Disease Mouse Model

2007 1.5k citations Kimberly Scearce‐Levie, Jorge J. Palop et al. profile →

Peers

Countries citing papers authored by Kimberly Scearce‐Levie

Since Specialization

Citations

This map shows the geographic impact of Kimberly Scearce‐Levie's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kimberly Scearce‐Levie with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kimberly Scearce‐Levie more than expected).

Fields of papers citing papers by Kimberly Scearce‐Levie

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kimberly Scearce‐Levie. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kimberly Scearce‐Levie. The network helps show where Kimberly Scearce‐Levie may publish in the future.

Co-authorship network of co-authors of Kimberly Scearce‐Levie

This figure shows the co-authorship network connecting the top 25 collaborators of Kimberly Scearce‐Levie. A scholar is included among the top collaborators of Kimberly Scearce‐Levie based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kimberly Scearce‐Levie. Kimberly Scearce‐Levie is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Leveraging preclinical models for the development of Alzheimer disease therapeutics 2020 ·Nature Reviews Drug Discovery ·Kimberly Scearce‐Levie,Pascal E. Sanchez,Joseph W. Lewcock	76
2	Aging: therapeutics for a healthy future 2019 ·Neuroscience & Biobehavioral Reviews ·Robert A. Hodgson,Brian K. Kennedy,Eliezer Masliah,Kimberly Scearce‐Levie,Barbara Tate,Anjli Venkateswaran,Steven P. Braithwaite	20
3	Mice deficient in NRROS show abnormal microglial development and neurological disorders 2017 ·Nature Immunology ·Kit Hong Wong,Rajkumar Noubade,Paolo Manzanillo,Naruhisa Ota,Oded Foreman,Jason A. Hackney,Brad A. Friedman,Rajita Pappu,Kimberly Scearce‐Levie,Wenjun Ouyang	48
4	Interfering with the Chronic Immune Response Rescues Chronic Degeneration After Traumatic Brain Injury 2016 ·Journal of Neuroscience ·Ali Ertürk,(unknown),(unknown),Maj Hedehus,Sara L. Domínguez,(unknown),(unknown),Gemma Llovera,Karpagam Srinivasan,Matthew H. Bailey,Arthur Liesz,Kimberly Scearce‐Levie,Morgan Sheng	68
5	Caspase-3 Deficiency Results in Disrupted Synaptic Homeostasis and Impaired Attention Control 2015 ·Journal of Neuroscience ·Shih‐Ching Lo,Yuan Yuan Wang,Martin Weber,Jessica L. Larson,Kimberly Scearce‐Levie,Morgan Sheng	31
6	Chronic GluN2B Antagonism Disrupts Behavior in Wild-Type Mice Without Protecting Against Synapse Loss or Memory Impairment in Alzheimer's Disease Mouse Models 2014 ·Journal of Neuroscience ·Julien Hanson,William J. Meilandt,Alvin Gogineni,Paul Reynen,James Herrington,Robby M. Weimer,Kimberly Scearce‐Levie,Qiang Zhou	19
7	GluN2B Antagonism Affects Interneurons and Leads to Immediate and Persistent Changes in Synaptic Plasticity, Oscillations, and Behavior 2013 ·Neuropsychopharmacology ·Jesse E. Hanson,Martin Weber,William J. Meilandt,Tiffany Wu,(unknown),Lunbin Deng,Mehrdad Shamloo,Morgan Sheng,Kimberly Scearce‐Levie,Qiang Zhou	44
8	Mechanistic Pharmacokinetic-Pharmacodynamic Modeling of BACE1 Inhibition in Monkeys: Development of a Predictive Model for Amyloid Precursor Protein Processing 2013 ·Drug Metabolism and Disposition ·Xingrong Liu,Harvey Wong,Kimberly Scearce‐Levie,Ryan J. Watts,Melis Coraggio,Young G. Shin,Kun Peng,Kristin R. Wildsmith,Jasvinder K. Atwal,(unknown),Stephen Schauer,Kelly Regal,Kevin W. Hunt,Allen A. Thomas,Michael Siu,Joseph P. Lyssikatos,Gauri Deshmukh,Cornelis E. C. A. Hop	17
9	SAHA Enhances Synaptic Function and Plasticity In Vitro but Has Limited Brain Availability In Vivo and Does Not Impact Cognition 2013 ·PLoS ONE ·Jesse E. Hanson,Hank La,Emile G. Plise,Yung‐Hsiang Chen,Xiao Ding,Taleen Hanania,Emily Sabath,Vadim Alexandrov,Dani Brunner,Emer Leahy,Pascal Steiner,Lichuan Liu,Kimberly Scearce‐Levie,Qiang Zhou	93
10	Monitoring Spatial Learning and Memory in Alzheimer’s Disease Mouse Models Using the Morris Water Maze 2010 ·Methods in molecular biology ·Kimberly Scearce‐Levie	17
11	Reduction in Mitochondrial Superoxide Dismutase Modulates Alzheimer's Disease-Like Pathology and Accelerates the Onset of Behavioral Changes in Human Amyloid Precursor Protein Transgenic Mice 2006 ·Journal of Neuroscience ·Luke Esposito,Jacob Raber,(unknown),Fengrong Yan,(unknown),Nga Bien‐Ly,Jukka Puoliväli,Kimberly Scearce‐Levie,Eliezer Masliah,Lennart Mucke	215
12	Fyn Kinase Induces Synaptic and Cognitive Impairments in a Transgenic Mouse Model of Alzheimer's Disease 2005 ·Journal of Neuroscience ·Jeannie Chin,Jorge J. Palop,Jukka Puoliväli,(unknown),Nga Bien‐Ly,Hertzel C. Gerstein,Kimberly Scearce‐Levie,Eliezer Masliah,Lennart Mucke	265
13	Enkephalin contributes to the locomotor stimulating effects of 3,4‐methylenedioxy‐N‐methylamphetamine 2003 ·European Journal of Neuroscience ·Valérie Compan,Kimberly Scearce‐Levie,(unknown),A. Daszuta,René Hen	18
14	Tools for dissecting signaling pathways in vivo: Receptors activated solely by synthetic ligands 2002 ·Methods in enzymology on CD-ROM/Methods in enzymology ·Kimberly Scearce‐Levie,Peter Coward,Charles H. Redfern,Bruce R. Conklin	5
15	Absence of Cocaine-induced Place Conditioning in Serotonin 1B Receptor Knock-out Mice 2000 ·Pharmacology Biochemistry and Behavior ·Catherine Belzung,Kimberly Scearce‐Levie,(unknown),René Hen	31
16	Modulation of the effects of cocaine by 5-HT1B receptors: a comparison of knockouts and antagonists 2000 ·Pharmacology Biochemistry and Behavior ·Nathalie Castanon,Kimberly Scearce‐Levie,José J. Lucas,Beatriz Rocha,René Hen	73
17	Locomotor response to MDMA is attenuated in knockout mice lacking the 5-HT 1B receptor 1999 ·Psychopharmacology ·Kimberly Scearce‐Levie,(unknown),René Hen	75
18	5‐HT Receptor Knockout Mice: Pharmacological Tools or Models of Psychiatric Disorders 1999 ·Annals of the New York Academy of Sciences ·Kimberly Scearce‐Levie,Jue Chen,Eliot L. Gardner,René Hen	49
19	5‐HT_1B Receptor Modulation of Prepulse Inhibition: Recent Findings in Wild‐type and 5‐HT_1B Knockout Mice^a 1998 ·Annals of the New York Academy of Sciences ·Stephanie C. Dulawa,René Hen,Kimberly Scearce‐Levie,Mark A. Geyer	31
20	Serotonin 1B receptor modulation of startle reactivity, habituation, and prepulse inhibition in wild-type and serotonin 1B knockout mice 1997 ·Psychopharmacology ·Stephanie C. Dulawa,René Hen,Kimberly Scearce‐Levie,Mark A. Geyer	105

About Kimberly Scearce‐Levie

Kimberly Scearce‐Levie is a scholar working on Cellular and Molecular Neuroscience, Biological Psychiatry and Neurology, having authored 55 papers that have together received 5.8k indexed citations. Recurring topics across this work include Alzheimer's disease research and treatments (20 papers), Neuroscience and Neuropharmacology Research (17 papers) and Neurotransmitter Receptor Influence on Behavior (10 papers). The work is most often cited by research in Cellular and Molecular Neuroscience (2.1k citations), Physiology (3.0k citations) and Neurology (896 citations). Kimberly Scearce‐Levie has collaborated with scholars based in United States, France and Singapore. Frequent co-authors include Lennart Mucke, Jorge J. Palop, Hertzel C. Gerstein, Irene H. Cheng, Tiffany Wu, Gui-Qiu Yu, Fengrong Yan, Erik D. Roberson, René Hen and Nga Bien‐Ly. Their work appears in journals such as Nature, Science and Proceedings of the National Academy of Sciences.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact